Labetuzumab govitecan Antibody
Labetuzumab govitecan is an antibody-drug conjugate targeting CEACAM5 and delivering the cytotoxic SN-38 for treating metastatic colorectal cancer. It is utilized in oncology research for investigating ADC mechanisms and efficacy in both in vitro cell studies and in vivo xenograft models.
Product Specifications
Target
Antibody-Drug Conjugates (ADCs), Immunology/Inflammation related
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC942408-500 1x 500 µL
CD14 (Monocyte / Macrophage Marker) (LPSR/2408), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681283-100 1x 100 µL
VEGI (Vascular Endothelial Growth Inhibitor) (VEGI/1283), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042042-500 1x 500 µL
Human IgG4 (Ig Heavy Constant Gamma 4) (G4m Marker) (IGHG4/2042R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741366-100 1x 100 µL
Adipophilin / Perilipin-2 (Marker of Obesity) (ADFP/1366), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details